"10.1371_journal.pone.0095900","plos one","2014-04-29T00:00:00Z","Daniel Ardeljan; Yujuan Wang; Stanley Park; Defen Shen; Xi Kathy Chu; Cheng-Rong Yu; Mones Abu-Asab; Jingsheng Tuo; Charles G Eberhart; Timothy W Olsen; Robert F Mullins; Gary White; Sam Wadsworth; Abraham Scaria; Chi-Chao Chan","Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America; Molecular Immunology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; Histology Core, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Ophthalmology, Emory University, Atlanta, Georgia, United States of America; Department of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Genzyme Corporation, Framingham, Massachusetts, United States of America","Conceived and designed the experiments: DA CCC. Performed the experiments: DA YW SP DFS XKC MAA JT GW CCC. Interpreted the data: DA CRY JT CCC. Contributed reagents/materials/analysis tools: CGE TWO RFM SW AS CCC. Wrote the paper: DA.","The authors would also like to make explicit their collaboration with Genzyme Corp. Three of the co-authors, GW, SW, and AS are employees of Genzyme, who funded their salaries. GW and AS are listed as inventors on a patent application held by the company. Patent application name: Composition and Methods for Inhibiting Interleukin Pathways and number WO 2009042162. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2014","04","Daniel Ardeljan","DA",15,TRUE,2,9,NA,1,TRUE,FALSE,FALSE,0,NA,FALSE
